Myositis and myasteniform syndrome related to pembrolizumab

Pablo Sanchez-Sancho; Albert Selva-O'Callaghan; Ernesto Trallero-Araguás; Javier Ros; Bruno Montoro

doi:10.1136/bcr-2021-241766

Article info

Case report

Myositis and myasteniform syndrome related to pembrolizumab

Authors

Pablo Sanchez-Sancho Pharmacy Department, Hospital Vall d'Hebron, Barcelona, Spain PubMed articles Google scholar articles
Albert Selva-O'Callaghan Systemic Autoimmune Diseases Unit, Hospital Vall d'Hebron, Barcelona, Spain PubMed articles Google scholar articles
Ernesto Trallero-Araguás Rheumatology Unit, Hospital Vall d'Hebron, Barcelona, Spain PubMed articles Google scholar articles
Javier Ros Medical Oncology, Hospital Vall d'Hebron, Barcelona, Spain PubMed articles Google scholar articles
Bruno Montoro Pharmacy Department, Hospital Vall d'Hebron, Barcelona, Spain PubMed articles Google scholar articles

Correspondence to Dr Pablo Sanchez-Sancho; pablo.sanchez.vhebron{at}gmail.com

View Full Text

Citation

Sanchez-Sancho P, Selva-O'Callaghan A, Trallero-Araguás E, et al

Myositis and myasteniform syndrome related to pembrolizumab

BMJ Case Reports CP 2021;14:e241766.

Publication history

Accepted May 12, 2021
First published July 21, 2021.

Online issue publication

July 21, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password